Please assess the completion status of the following clinical trial:

Trial Title: Plasma Concentration of Biological Markers in Placenta Accreta Spectrum

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 18 - to 45-years old, inclusive~* Suspected or confirmed PAS or phenotypically matched controls~* Delivery by cesarean section~* Gestational age greater than 28 weeks~* Singleton pregnancy~Exclusion Criteria:~* Intrauterine fetal demise,~* Severe fetal anomalies (infant not expected to survive)~* Emergent cesarean delivery

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Placenta accreta spectrum (Type: None): Mother-infant dyads with suspected or confirmed diagnosis of placenta accreta spectrum
- Phenotypically-matched controlled group (Type: None): Mother-infant dyads admitted for delivery without placenta accreta spectrum

Based on this trial design, predict the completion outcome and termination type (if applicable).